EXPLORING IGALMI’S POTENTIAL: MARKET GROWTH AND PATIENT BENEFITS

Schizophrenia is a severe mental disorder that affects how individuals think, feel, and behave. Despite being relatively rare, with an estimated global prevalence of around 1%, it presents significant challenges for both patients and healthcare professionals. Traditional treatments such as antipsychotics have been the cornerstone of managing schizo